Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Zhongnan Pharmaceutical Co., Ltd. is a Chinese pharmaceutical manufacturing company based in Shaoyang, Hunan Province. Established in 2002 following the restructuring of the state-owned Zhongnan Pharmaceutical Factory, the company specializes in the production of chemical active pharmaceutical ingredients (APIs) and solid oral preparations. Its product portfolio includes well-known generic drugs and formulations such as aspirin, penfluridol, orazamide, trihexyphenidyl hydrochloride, and compound proglumide tablets. The company operates large-scale manufacturing facilities that comply with national Good Manufacturing Practice (GMP) standards, serving both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hunan Zhongnan Pharmaceutical.